Our Pipeline

Best-in-Class, Oral Drugs for Inflammatory and Metabolic Diseases

Project

Lead Optimization

Pre-Clinical

Phase 1

Phase 2

Phase 3

URAT1 inhibitor

Gout & Hyperuricemia
Chronic Kidney Disease
Refactory Gout
Acute Gout & Other Indications

Xanthine Oxidase Inhibitor

Gout

ABP-431

Anticancer